publication venue for
- Clarithromycin For Improved Clinical Outcomes in Community-Acquired Pneumonia: A Subgroup Analysis of the ACCESS Study. 2024
- Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance.. 55. 2020
- Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.. 55. 2019
- Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.. 52. 2018
- Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads.. 43. 2013
- Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.. 38. 2011
- Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance.. 26. 2005
- In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.. 15. 2000
- Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice.. 15. 2000
- Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.. 42. 2013
- Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis. 2018
- A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. 2005